 | • レポートコード：B-GIR05A432 • 出版社/出版日：GlobalInfoResearch / 2019年5月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英語、PDF、118ページ • 納品方法：Eメール • 産業分類：化学・材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートでは、ワクチンコンジュゲートの世界市場について調査・分析し、ワクチンコンジュゲートの世界市場概観、メーカー動向、メーカー別ワクチンコンジュゲートシェア、市場規模推移、市場規模予測、ワクチンコンジュゲート種類別分析（一価、多価、その他）、ワクチンコンジュゲート用途別分析（Influenza、Meningococcal、Pneumococcal、Others）、主要地域分析（北米、欧州、アジア）、主要国分析データなどを含め、以下の構成でお届け致します。 ・ワクチンコンジュゲートの市場概観 ・ワクチンコンジュゲートのメーカー概要（事業概要、製品種類、価格、売上、市場シェア等） ・ワクチンコンジュゲートのメーカー別販売動向、市場シェア、市場集中度、競争動向 ・ワクチンコンジュゲートの世界市場規模 ・ワクチンコンジュゲートの北米市場分析（アメリカ、カナダ、メキシコ等） ・ワクチンコンジュゲートのアメリカ市場規模推移 ・ワクチンコンジュゲートのカナダ市場規模推移 ・ワクチンコンジュゲートのメキシコ市場規模推移 ・ワクチンコンジュゲートのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ワクチンコンジュゲートのドイツ市場規模推移 ・ワクチンコンジュゲートのイギリス市場規模推移 ・ワクチンコンジュゲートのロシア市場規模推移 ・ワクチンコンジュゲートのアジア市場分析（日本、中国、韓国、インド、東南アジア等） ・ワクチンコンジュゲートの日本市場規模推移 ・ワクチンコンジュゲートの中国市場規模推移 ・ワクチンコンジュゲートの韓国市場規模推移 ・ワクチンコンジュゲートのインド市場規模推移 ・ワクチンコンジュゲートの東南アジア市場規模推移 ・ワクチンコンジュゲートの南米・中東・アフリカ市場分析 ・ワクチンコンジュゲートの種類別分析/市場規模推移（一価、多価、その他） ・ワクチンコンジュゲートの用途別分析/市場規模推移（Influenza、Meningococcal、Pneumococcal、Others） ・ワクチンコンジュゲートの市場予測（地域別予測、種類別予測、用途別予測） ・ワクチンコンジュゲートの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Vaccine Conjugate is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Vaccine Conjugate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
[Market Segment by Manufacturers, this report covers]
Merck & Co., Inc.
GlaxoSmithKline plc.
SutroVax Inc.
Fablife.
Pfizer
Sinovac Biotech Ltd.
Sanofi Pasteur SA.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monovalent
Multivalent
Others
Market Segment by Applications, can be divided into
Influenza
Meningococcal
Pneumococcal
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine Conjugate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccine Conjugate, with price, sales, revenue and global market share of Vaccine Conjugate in 2017 and 2018.
Chapter 3, the Vaccine Conjugate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine Conjugate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Vaccine Conjugate market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Vaccine Conjugate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Vaccine Conjugate Introduction
1.2 Market Analysis by Type
1.2.1 Monovalent
1.2.2 Multivalent
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Influenza
1.3.2 Meningococcal
1.3.3 Pneumococcal
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck & Co., Inc.
2.1.1 Business Overview
2.1.2 Vaccine Conjugate Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck & Co., Inc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GlaxoSmithKline plc.
2.2.1 Business Overview
2.2.2 Vaccine Conjugate Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline plc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 SutroVax Inc.
2.3.1 Business Overview
2.3.2 Vaccine Conjugate Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 SutroVax Inc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Fablife.
2.4.1 Business Overview
2.4.2 Vaccine Conjugate Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Fablife. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Vaccine Conjugate Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sinovac Biotech Ltd.
2.6.1 Business Overview
2.6.2 Vaccine Conjugate Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sinovac Biotech Ltd. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sanofi Pasteur SA.
2.7.1 Business Overview
2.7.2 Vaccine Conjugate Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Pasteur SA. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Vaccine Conjugate Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Vaccine Conjugate Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Vaccine Conjugate Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Vaccine Conjugate Manufacturer Market Share in 2018
3.3.2 Top 6 Vaccine Conjugate Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Vaccine Conjugate Market Analysis by Regions
4.1 Global Vaccine Conjugate Sales, Revenue and Market Share by Regions
4.1.1 Global Vaccine Conjugate Sales and Market Share by Regions (2014-2019)
4.1.2 Global Vaccine Conjugate Revenue and Market Share by Regions (2014-2019)
4.2 North America Vaccine Conjugate Sales and Growth Rate (2014-2019)
4.3 Europe Vaccine Conjugate Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Vaccine Conjugate Sales and Growth Rate (2014-2019)
4.5 South America Vaccine Conjugate Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Vaccine Conjugate Sales and Growth Rate (2014-2019)
5 North America Vaccine Conjugate by Country
5.1 North America Vaccine Conjugate Sales, Revenue and Market Share by Country
5.1.1 North America Vaccine Conjugate Sales and Market Share by Country (2014-2019)
5.1.2 North America Vaccine Conjugate Revenue and Market Share by Country (2014-2019)
5.2 United States Vaccine Conjugate Sales and Growth Rate (2014-2019)
5.3 Canada Vaccine Conjugate Sales and Growth Rate (2014-2019)
5.4 Mexico Vaccine Conjugate Sales and Growth Rate (2014-2019)
6 Europe Vaccine Conjugate by Country
6.1 Europe Vaccine Conjugate Sales, Revenue and Market Share by Country
6.1.1 Europe Vaccine Conjugate Sales and Market Share by Country (2014-2019)
6.1.2 Europe Vaccine Conjugate Revenue and Market Share by Country (2014-2019)
6.2 Germany Vaccine Conjugate Sales and Growth Rate (2014-2019)
6.3 UK Vaccine Conjugate Sales and Growth Rate (2014-2019)
6.4 France Vaccine Conjugate Sales and Growth Rate (2014-2019)
6.5 Russia Vaccine Conjugate Sales and Growth Rate (2014-2019)
6.6 Italy Vaccine Conjugate Sales and Growth Rate (2014-2019)
7 Asia-Pacific Vaccine Conjugate by Country
7.1 Asia-Pacific Vaccine Conjugate Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Vaccine Conjugate Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Vaccine Conjugate Revenue and Market Share by Country (2014-2019)
7.2 China Vaccine Conjugate Sales and Growth Rate (2014-2019)
7.3 Japan Vaccine Conjugate Sales and Growth Rate (2014-2019)
7.4 Korea Vaccine Conjugate Sales and Growth Rate (2014-2019)
7.5 India Vaccine Conjugate Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Vaccine Conjugate Sales and Growth Rate (2014-2019)
8 South America Vaccine Conjugate by Country
8.1 South America Vaccine Conjugate Sales, Revenue and Market Share by Country
8.1.1 South America Vaccine Conjugate Sales and Market Share by Country (2014-2019)
8.1.2 South America Vaccine Conjugate Revenue and Market Share by Country (2014-2019)
8.2 Brazil Vaccine Conjugate Sales and Growth Rate (2014-2019)
8.3 Argentina Vaccine Conjugate Sales and Growth Rate (2014-2019)
8.4 Colombia Vaccine Conjugate Sales and Growth Rate (2014-2019)
9 Middle East and Africa Vaccine Conjugate by Countries
9.1 Middle East and Africa Vaccine Conjugate Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Vaccine Conjugate Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Vaccine Conjugate Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Vaccine Conjugate Sales and Growth Rate (2014-2019)
9.3 Turkey Vaccine Conjugate Sales and Growth Rate (2014-2019)
9.4 Egypt Vaccine Conjugate Sales and Growth Rate (2014-2019)
9.5 Nigeria Vaccine Conjugate Sales and Growth Rate (2014-2019)
9.6 South Africa Vaccine Conjugate Sales and Growth Rate (2014-2019)
10 Global Vaccine Conjugate Market Segment by Type
10.1 Global Vaccine Conjugate Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Vaccine Conjugate Sales and Market Share by Type (2014-2019)
10.1.2 Global Vaccine Conjugate Revenue and Market Share by Type (2014-2019)
10.2 Monovalent Sales Growth and Price
10.2.1 Global Monovalent Sales Growth (2014-2019)
10.2.2 Global Monovalent Price (2014-2019)
10.3 Multivalent Sales Growth and Price
10.3.1 Global Multivalent Sales Growth (2014-2019)
10.3.2 Global Multivalent Price (2014-2019)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2014-2019)
10.4.2 Global Others Price (2014-2019)
11 Global Vaccine Conjugate Market Segment by Application
11.1 Global Vaccine Conjugate Sales Market Share by Application (2014-2019)
11.2 Influenza Sales Growth (2014-2019)
11.3 Meningococcal Sales Growth (2014-2019)
11.4 Pneumococcal Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Vaccine Conjugate Market Forecast (2019-2024)
12.1 Global Vaccine Conjugate Sales, Revenue and Growth Rate (2019-2024)
12.2 Vaccine Conjugate Market Forecast by Regions (2019-2024)
12.2.1 North America Vaccine Conjugate Market Forecast (2019-2024)
12.2.2 Europe Vaccine Conjugate Market Forecast (2019-2024)
12.2.3 Asia-Pacific Vaccine Conjugate Market Forecast (2019-2024)
12.2.4 South America Vaccine Conjugate Market Forecast (2019-2024)
12.2.5 Middle East and Africa Vaccine Conjugate Market Forecast (2019-2024)
12.3 Vaccine Conjugate Market Forecast by Type (2019-2024)
12.3.1 Global Vaccine Conjugate Sales Forecast by Type (2019-2024)
12.3.2 Global Vaccine Conjugate Market Share Forecast by Type (2019-2024)
12.4 Vaccine Conjugate Market Forecast by Application (2019-2024)
12.4.1 Global Vaccine Conjugate Sales Forecast by Application (2019-2024)
12.4.2 Global Vaccine Conjugate Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Vaccine Conjugate Picture
Table Product Specifications of Vaccine Conjugate
Figure Global Sales Market Share of Vaccine Conjugate by Types in 2018
Table Vaccine Conjugate Types for Major Manufacturers
Figure Monovalent Picture
Figure Multivalent Picture
Figure Others Picture
Figure Vaccine Conjugate Sales Market Share by Applications in 2018
Figure Influenza Picture
Figure Meningococcal Picture
Figure Pneumococcal Picture
Figure Others Picture
Figure United States Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure France Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure UK Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure China Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure India Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Vaccine Conjugate Revenue (Value) and Growth Rate (2014-2024)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Vaccine Conjugate Type and Applications
Table Merck & Co., Inc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc. Vaccine Conjugate Type and Applications
Table GlaxoSmithKline plc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table SutroVax Inc. Basic Information, Manufacturing Base and Competitors
Table SutroVax Inc. Vaccine Conjugate Type and Applications
Table SutroVax Inc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Fablife. Basic Information, Manufacturing Base and Competitors
Table Fablife. Vaccine Conjugate Type and Applications
Table Fablife. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Vaccine Conjugate Type and Applications
Table Pfizer Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sinovac Biotech Ltd. Basic Information, Manufacturing Base and Competitors
Table Sinovac Biotech Ltd. Vaccine Conjugate Type and Applications
Table Sinovac Biotech Ltd. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Pasteur SA. Basic Information, Manufacturing Base and Competitors
Table Sanofi Pasteur SA. Vaccine Conjugate Type and Applications
Table Sanofi Pasteur SA. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Vaccine Conjugate Sales by Manufacturer (2017-2018)
Figure Global Vaccine Conjugate Sales Market Share by Manufacturer in 2017
Figure Global Vaccine Conjugate Sales Market Share by Manufacturer in 2018
Table Global Vaccine Conjugate Revenue by Manufacturer (2017-2018)
Figure Global Vaccine Conjugate Revenue Market Share by Manufacturer in 2017
Figure Global Vaccine Conjugate Revenue Market Share by Manufacturer in 2018
Figure Top 3 Vaccine Conjugate Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Vaccine Conjugate Manufacturer (Revenue) Market Share in 2018
Figure Global Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Global Vaccine Conjugate Revenue and Growth Rate (2014-2019)
Table Global Vaccine Conjugate Sales by Regions (2014-2019)
Table Global Vaccine Conjugate Sales Market Share by Regions (2014-2019)
Table Global Vaccine Conjugate Revenue by Regions (2014-2019)
Figure Global Vaccine Conjugate Revenue Market Share by Regions in 2014
Figure Global Vaccine Conjugate Revenue Market Share by Regions in 2018
Figure North America Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Europe Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure South America Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure North America Vaccine Conjugate Revenue and Growth Rate (2014-2019)
Table North America Vaccine Conjugate Sales by Countries (2014-2019)
Table North America Vaccine Conjugate Sales Market Share by Countries (2014-2019)
Figure North America Vaccine Conjugate Sales Market Share by Countries in 2014
Figure North America Vaccine Conjugate Sales Market Share by Countries in 2018
Table North America Vaccine Conjugate Revenue by Countries (2014-2019)
Table North America Vaccine Conjugate Revenue Market Share by Countries (2014-2019)
Figure North America Vaccine Conjugate Revenue Market Share by Countries in 2014
Figure North America Vaccine Conjugate Revenue Market Share by Countries in 2018
Figure United States Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Canada Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Mexico Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Europe Vaccine Conjugate Revenue and Growth Rate (2014-2019)
Table Europe Vaccine Conjugate Sales by Countries (2014-2019)
Table Europe Vaccine Conjugate Sales Market Share by Countries (2014-2019)
Table Europe Vaccine Conjugate Revenue by Countries (2014-2019)
Figure Europe Vaccine Conjugate Revenue Market Share by Countries in 2017
Figure Europe Vaccine Conjugate Revenue Market Share by Countries in 2018
Figure Germany Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure UK Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure France Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Russia Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Italy Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Vaccine Conjugate Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Vaccine Conjugate Sales by Countries (2014-2019)
Table Asia-Pacific Vaccine Conjugate Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Vaccine Conjugate Sales Market Share by Countries 2018
Table Asia-Pacific Vaccine Conjugate Revenue by Countries (2014-2019)
Figure Asia-Pacific Vaccine Conjugate Revenue Market Share by Countries 2018
Figure China Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Japan Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Korea Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure India Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Southeast Asia Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure South America Vaccine Conjugate Revenue and Growth Rate (2014-2019)
Table South America Vaccine Conjugate Sales by Countries (2014-2019)
Table South America Vaccine Conjugate Sales Market Share by Countries (2014-2019)
Figure South America Vaccine Conjugate Sales Market Share by Countries in 2018
Table South America Vaccine Conjugate Revenue by Countries (2014-2019)
Table South America Vaccine Conjugate Revenue Market Share by Countries (2014-2019)
Figure South America Vaccine Conjugate Revenue Market Share by Countries in 2018
Figure Brazil Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Argentina Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Colombia Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Vaccine Conjugate Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Vaccine Conjugate Sales by Countries (2014-2019)
Table Middle East and Africa Vaccine Conjugate Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Vaccine Conjugate Sales Market Share by Countries in 2018
Table Middle East and Africa Vaccine Conjugate Revenue by Countries (2014-2019)
Table Middle East and Africa Vaccine Conjugate Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Vaccine Conjugate Revenue Market Share by Countries in 2014
Figure Middle East and Africa Vaccine Conjugate Revenue Market Share by Countries in 2018
Figure Saudi Arabia Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure UAE Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Egypt Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure Nigeria Vaccine Conjugate Sales and Growth Rate (2014-2019)
Figure South Africa Vaccine Conjugate Sales and Growth Rate (2014-2019)
Table Global Vaccine Conjugate Sales by Type (2014-2019)
Table Global Vaccine Conjugate Sales Share by Type (2014-2019)
Table Global Vaccine Conjugate Revenue by Type (2014-2019)
Table Global Vaccine Conjugate Revenue Share by Type (2014-2019)
Figure Global Monovalent Sales Growth (2014-2019)
Figure Global Monovalent Price (2014-2019)
Figure Global Multivalent Sales Growth (2014-2019)
Figure Global Multivalent Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Vaccine Conjugate Sales by Application (2014-2019)
Table Global Vaccine Conjugate Sales Share by Application (2014-2019)
Figure Global Meningococcal Sales Growth (2014-2019)
Figure Global Pneumococcal Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Vaccine Conjugate Sales, Revenue and Growth Rate (2019-2024)
Table Global Vaccine Conjugate Sales Forecast by Regions (2019-2024)
Table Global Vaccine Conjugate Market Share Forecast by Regions (2019-2024)
Figure North America Sales Vaccine Conjugate Market Forecast (2019-2024)
Figure Europe Sales Vaccine Conjugate Market Forecast (2019-2024)
Figure Asia-Pacific Sales Vaccine Conjugate Market Forecast (2019-2024)
Figure South America Sales Vaccine Conjugate Market Forecast (2019-2024)
Figure Middle East and Africa Sales Vaccine Conjugate Market Forecast (2019-2024)
Table Global Vaccine Conjugate Sales Forecast by Type (2019-2024)
Table Global Vaccine Conjugate Market Share Forecast by Type (2019-2024)
Table Global Vaccine Conjugate Sales Forecast by Application (2019-2024)
Table Global Vaccine Conjugate Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
シングルユースバイオプロセッシングの世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Single-use Bioprocessing is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Single-use Bioprocessing…